Dr. Robert Wittes, MD,
MSc, CCFP, FRCP, CTH
did a Fellowship at the US Centers for Disease Control in the
Division of Parasitic Diseases. There, I did research on
schistosomiasis (also known as bilharzia), so prevalent in South
America, Asia, and Africa.
I was Chief of Tropical Health
and Quarantine for Health Canada. There, I initiated the first
Canadian clinical trial of the anti-malarial drug Mefloquine (Lariam) for use by Canadian travellers.
For a decade, I was Medical
Director at Connaught Laboratories (now Aventis), the world’s
largest vaccine manufacturer. There, I directed clinical trials
involving many travel vaccines. (I was also instrumental in getting
the bacteria BCG licensed as a treatment for bladder cancer).
have done cancer research in the specialized area known as
“immunotherapy,” using bacteria to try to stimulate the patient’s
own immune system to recognize and fight the cancer.
I have been on staff in the
Tropical Disease Clinics of the Montreal General Hospital, the
Ottawa Civic Hospital, and the Toronto General Hospital.
- I have been on staff in
Uro-Oncology at Princess Margaret Hospital in Toronto.
- I have held Faculty
appointments at the University of Toronto, the University of
Ottawa, and McGill University.
- Throughout a career
involving much research and public health practice, I have
nevertheless always maintained a clinical practice in both
Family Medicine and in Travel/Tropical medicine.
- I currently have active
admitting privileges in Family Medicine at York Central Hospital
in Richmond Hill, where I serve on the hospital's Ethics Board.